Merck's alendronate patent: the EPO rules Merck's alendronate patent: the EPO rules Reviewed by Jeremy on Sunday, March 22, 2009 Rating: 5

Friday fiddlings

Don't forget to check for Forthcoming Events in the IPKat's left-hand side-bar. As usual, FREE events are listed in BLUE . Right no...
- Friday, March 20, 2009
Friday fiddlings Friday fiddlings Reviewed by Jeremy on Friday, March 20, 2009 Rating: 5
Double Patenting at the EPO - a new view Double Patenting at the EPO - a new view Reviewed by David Pearce on Friday, March 20, 2009 Rating: 5
OHIM system delays: the world waits OHIM system delays: the world waits Reviewed by Jeremy on Thursday, March 19, 2009 Rating: 5
UDV v Brandtraders -- the case that nearly got away UDV v Brandtraders -- the case that nearly got away Reviewed by Jeremy on Thursday, March 19, 2009 Rating: 5
AdWords and keywords everywhere AdWords and keywords everywhere Reviewed by Birgit Clark on Tuesday, March 17, 2009 Rating: 5
ECJ Antartica case - trade mark use and dilution ECJ Antartica case - trade mark use and dilution Reviewed by Anonymous on Tuesday, March 17, 2009 Rating: 5
BREAKING NEWS: pharma responses now online BREAKING NEWS: pharma responses now online Reviewed by Jeremy on Monday, March 16, 2009 Rating: 5

Waxman bill rises from the ashes

The IPKat's friend Annsley Merelle Ward (Gallant Macmillan LLP) has been busily tracking the latest developments in the US with regard ...
- Monday, March 16, 2009
Waxman bill rises from the ashes Waxman bill rises from the ashes Reviewed by Jeremy on Monday, March 16, 2009 Rating: 5

Monday medley

Last chance ... to register for CLT's conference this Thursday, IP in the Educational Sector , being held at Holborn Bars, London (detai...
- Monday, March 16, 2009
Monday medley Monday medley Reviewed by Jeremy on Monday, March 16, 2009 Rating: 5
Powered by Blogger.